Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Irritable bowel syndrome: Epidemiology, overlap disorders, pathophysiology and treatment
Kai-Yue Huang, Fengyun Wang, Mi Lv, et al.
World Journal of Gastroenterology (2023) Vol. 29, Iss. 26, pp. 4120-4135
Open Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

Chronic Gastrointestinal Disorders and miRNA-Associated Disease: An Up-to-Date
Alessandro Giammona, Bruno G. Galuzzi, Elena Imperia, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 1, pp. 413-413
Open Access
Neurogastroenterology and motility disorders in patients with cirrhosis
Francisco Idalsoaga, Gustavo Ayares, Hanna Blaney, et al.
Hepatology Communications (2025) Vol. 9, Iss. 1
Open Access
Influential articles in autism and gut microbiota: bibliometric profile and research trends
Jiangbo Ying, Melvyn Zhang, Ker‐Chiah Wei, et al.
Frontiers in Microbiology (2025) Vol. 15
Open Access
Impact of Microbiota on Irritable Bowel Syndrome Pathogenesis and Management: A Narrative Review
Mhd Bashir Almonajjed, Mahdi Wardeh, Abdallah Atlagh, et al.
Medicina (2025) Vol. 61, Iss. 1, pp. 109-109
Open Access
Specialty laboratory testing for chronic abdominal pain in irritable bowel syndrome
Michael Cymbal, Arjun B. Chatterjee, Patricia Ajayi-Fox, et al.
Scandinavian Journal of Gastroenterology (2025), pp. 1-5
Closed Access
Prescription of commonly used drugs in patients with functional bowel disorders. A cross-sectional comparison with the general population
Alice Sandberg-Janzon, Pontus Karling
Scandinavian Journal of Gastroenterology (2025), pp. 1-9
Open Access
Dietary Inflammatory and Glycemic Indices in Newly Diagnosed Irritable Bowel Syndrome Patients Compared to Healthy People: A Case-Control Study
Karim Shahbazi, Maryam Jameshorani, Amir Mahmoodkhani, et al.
Journal of Human Environment and Health Promotion (2025) Vol. 11, Iss. 1, pp. 19-26
Open Access
Gender-specific insights into the irritable bowel syndrome pathophysiology. Focus on gut dysbiosis and permeability
Jerlin Stephy JohnBritto, Agostino Di Ciaula, Antonino Noto, et al.
European Journal of Internal Medicine (2024) Vol. 125, pp. 10-18
Closed Access | Times Cited: 5
Metabolic biomarkers in irritable bowel syndrome diagnosis
Omid Vakili, Peyman Adibi, Morteza Pourfarzam
Clinica Chimica Acta (2024) Vol. 560, pp. 119753-119753
Closed Access | Times Cited: 2
Relationship between Markers of Gut Barrier Function and Erythrocyte Membrane PUFAs in Diarrhea-Predominant IBS Patients Undergoing a Low-FODMAP Diet
Michele Linsalata, Antonia Ignazzi, Benedetta D’Attoma, et al.
Nutrients (2024) Vol. 16, Iss. 16, pp. 2706-2706
Open Access | Times Cited: 2
Immune cell signatures and causal association with irritable bowel syndrome: A mendelian randomization study
Wei-Hao Chai, Yan Ma, Jia-Jia Li, et al.
World Journal of Clinical Cases (2024) Vol. 12, Iss. 17, pp. 3094-3104
Open Access | Times Cited: 1
Global research states and trends of micro RNA in irritable bowel syndrome: a bibliometric analysis
Hongxiu Chen, Zhifang Xu, Honggang Zhao, et al.
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Role of Bacillus coagulans (Heyndrickxia coagulans)BCP92 in managing irritable bowel syndrome: A randomized, double-blind, multicenter, placebo-controlled clinical trial
S. S. Shaikh, Sanjay Kumar
Medicine (2024) Vol. 103, Iss. 31, pp. e39134-e39134
Open Access | Times Cited: 1
The Latest Data Concerning the Etiology and Pathogenesis of Irritable Bowel Syndrome
Vlad Ionescu, Gina Gheorghe, Teodor Florin Georgescu, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 17, pp. 5124-5124
Open Access | Times Cited: 1
Inflammatory bowel diseases and spondyloarthritis: a focus on female patients
C Caranfil, Greta Lorenzon, Brigida Barberio, et al.
Reumatismo (2024) Vol. 76, Iss. 3
Open Access | Times Cited: 1
Impact of Enteric Nervous Cells on Irritable Bowel Syndrome: Potential Treatment Options
Ploutarchos Pastras, Ιωάννα Αγγελετοπούλου, Christos Triantos
Microorganisms (2024) Vol. 12, Iss. 10, pp. 2036-2036
Open Access | Times Cited: 1
Prevalence of and factors associated with symptoms consistent with a diagnosis of irritable bowel syndrome among resident physicians in standardised training in China: a cross-sectional study
Jun Zhao, Xia Li, Jiayi Yang, et al.
BMJ Open (2023) Vol. 13, Iss. 12, pp. e079874-e079874
Open Access | Times Cited: 2
Comorbid functional pathology in gastroenterology. Possibilities and prospects for drug treatment: A review
А. М. Осадчук, I. D. Loranskaya, М. А. Осадчук
Consilium Medicum (2024) Vol. 25, Iss. 12, pp. 844-848
Open Access
Grapefruit Seed Extract Reduces Gastrointestinal Symptoms
Bernhard Uehleke, Martin Storr, Martin Hörning
Zeitschrift für Phytotherapie (2024) Vol. 45, Iss. 02, pp. 54-60
Closed Access
Pharmacokinetic considerations for drugs that treat diarrhea-predominant irritable bowel syndrome: what’s new?
Shilan Mozaffari, Shekoufeh Nikfar, Mohammad Abdollahi
Expert Opinion on Drug Metabolism & Toxicology (2024) Vol. 20, Iss. 5, pp. 307-317
Closed Access
Xin-Jia-Tong-Xie-Yao-Fang Restores the Intestinal Barrier to Alleviate Irritable Bowel Syndrome Via Microbial Butyrate Mediated Pi3k/Akt Pathway Suppression
Jiajie Zhu, Shan Liu, Liangjun Yang, et al.
(2024)
Closed Access
Current and future pharmacotherapies for the management of constipation-predominant irritable bowel syndrome
Olga Biniszewska, Damian Jacenik, Aleksandra Tarasiuk, et al.
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 8, pp. 1039-1049
Closed Access
The possibility of Bacillus probiotic use in patients with post-infectious irritable bowel syndrome after COVID-19 infection
Ihor Hospodarskyy, L. A. Hryshchuk, T.V. Boyko
GASTROENTEROLOGY (2024) Vol. 58, Iss. 2, pp. 121-128
Open Access
ZO-1 and IL-1RAP Phosphorylation: Potential Role in Mediated Brain-Gut Axis Dysregulation in Irritable Bowel Syndrome-like Stressed Mice
Yuqin He, Jian-Ru Zhu, Wenjing Sun, et al.
International Journal of Medical Sciences (2024) Vol. 21, Iss. 9, pp. 1738-1755
Open Access
Síndrome do intestino irritável: abordagens modernas para diagnóstico e manejo eficaz
Lucas Rodrigues, Raphael Alves Moirinho, Natália Letícia Santos, et al.
Contribuciones a las Ciencias Sociales (2024) Vol. 17, Iss. 8, pp. e9316-e9316
Open Access
Page 1 - Next Page

Scroll to top